Evidence map›Paper›PMID 34652033›Full record

ArticleJournal of clinical laboratory analysis2021

Application of a six sigma model to evaluate the analytical performance of urinary biochemical analytes and design a risk-based statistical quality control strategy for these assays: A multicenter study.

Qian Liu, Guangrong Bian, Xinkuan Chen, Jingjing Han, Ying Chen, Menglin Wang, Fumeng Yang

Abstract readMulticenter Study
In one paragraph

Article in Journal of clinical laboratory analysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qian LiuDepartment of Laboratory Medicine, The Second People's Hospital of Lianyungang, Lianyungang, China.
Guangrong BianDepartment of Laboratory Medicine, The Second People's Hospital of Lianyungang, Lianyungang, China.
Xinkuan ChenDepartment of Laboratory Medicine, Xuzhou Medical University Affiliated Hospital of Lianyungang, Lianyungang, China.
Jingjing HanDepartment of Laboratory Medicine, Wuxi Branch of Ruijin Hospital, Wuxi, China.
Ying ChenDepartment of Laboratory Medicine, Nantong Hospital of Traditional Chinese Medicine, Nantong, China.
Menglin WangDepartment of Laboratory Medicine, Suqian First Hospital, Suqian, China.
Fumeng YangDepartment of Laboratory Medicine, The Second People's Hospital of Lianyungang, Lianyungang, China.ORCID https://orcid.org/0000-0002-2636-7340

Funding

Jiangsu Commission of Health M2020079Key Project of the Natural Science Foundation of Bengbu Medical College 2020byzd342
6 · The paper itself

Abstract

backgroundThe six sigma model has been widely used in clinical laboratory quality management. In this study, we first applied the six sigma model to (a) evaluate the analytical performance of urinary biochemical analytes across five laboratories, (b) design risk-based statistical quality control (SQC) strategies, and (c) formulate improvement measures for each of the analytes when needed.

methodsInternal quality control (IQC) and external quality assessment (EQA) data for urinary biochemical analytes were collected from five laboratories, and the sigma value of each analyte was calculated based on coefficients of variation, bias, and total allowable error (TEa). Normalized sigma method decision charts for these urinary biochemical analytes were then generated. Risk-based SQC strategies and improvement measures were formulated for each laboratory according to the flowchart of Westgard sigma rules, including run sizes and the quality goal index (QGI).

resultsSigma values of urinary biochemical analytes were significantly different at different quality control levels. Although identical detection platforms with matching reagents were used, differences in these analytes were also observed between laboratories. Risk-based SQC strategies for urinary biochemical analytes were formulated based on the flowchart of Westgard sigma rules, including run size and analytical performance. Appropriate improvement measures were implemented for urinary biochemical analytes with analytical performance lower than six sigma according to the QGI calculation.

conclusionsIn multilocation laboratory systems, a six sigma model is an excellent quality management tool and can quantitatively evaluate analytical performance and guide risk-based SQC strategy development and improvement measure implementation.

Indexed as

Total Quality ManagementUrinalysisBiomarkersHumansLaboratories, ClinicalQuality ControlReference StandardsBiomarkersanalytical performancequality goal indexrisk-based statistical quality control strategysix sigmaurinary biochemical analytes

Identifiers

PMID34652033
PMCPMC8605169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.